Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Paint The Table -- Ignore unavailable to you. Want to Upgrade?

To: iris263 who wrote (22748)	4/1/2002 3:54:51 PM
From: Jorj X Mckie	Read Replies (1) \| Respond to of 23786

Well gee Iris, isn't it pretty obvious? Most people don't start off being an asshole and certainly wouldn't feel comfortable using my real name. BTW: what do you have against Mrs. Peel?

To: iris263 who wrote (22748)	4/1/2002 4:23:04 PM
From: Jorj X Mckie	Respond to of 23786

From briefing.com 16:17 ET NOVN Noven Pharma sees New Drug Application for MethyPatch mid-2002 (20.00 -0.74) Company announces it has completed an initial review of the primary efficacy data from its recently completed Phase III clinical trial for once-daily MethyPatch; based on these results company expects to file a New Drug Application for MethyPatch with the U.S. Food and Drug Administration (FDA) in mid-2002. 16:16 ET DCTM Documentum preannounces higher than expected Q1 revenue (24.61 -0.84) -- Update -- Co preannounces that Q1 rev will be about $50 mln, exceeding the consensus rev est of $48.5 mln. 16:13 ET BVSN BroadVision guides lower; releases restated results (1.72 -0.01) -- Update -- Company announces it expects Q1 revenue to range between $29 million and $32 million versus the current consensus estimate of $40.1 million; separately company announce restated financial results for the third quarter and revised results for the fourth quarter and fiscal year ended December 31, 2001. These results are reflected in the company's 2001 Annual Report on Form 10-K and third quarter report on Form 10-Q being filed today. Total revenue for the third quarter of 2001 decreased by $3.5 million from $51.2 million as originally reported to $47.7 million as restated, and basic pro forma loss per share for the third quarter of 2001 increased from $0.06 to $0.07. Fourth quarter revenue increased by $250,000. 16:11 ET EPNY E.piphany lowers Q1 guidance (7.19 -0.37) Co announces that rev for Q1 will be approximately $22.0 mln, below the current consensus of $28.1 mln, primarily due to not recognizing revenue from a previously announced transaction that was forecasted to be recognized during Q1; the co is expecting a net loss of $0.20, lower than the consensus of a loss of $0.14. 16:07 ET BVSN BroadVision Halted (1.72 -0.01) 16:05 ET DCTM Documentum to offer $100 million in convertible notes (24.61 -0.84) -- Update -- Company announces it intends to offer $100 million of senior convertible notes for sale ($115 million if an option for an additional $15 million is exercised in full), subject to market and other conditions. The notes will be offered to qualified institutional buyers under Rule 144A.

To: iris263 who wrote (22748)	4/1/2002 4:45:59 PM
From: Jorj X Mckie	Respond to of 23786

from briefing.com 16:44 ET LMNX Luminex warns for Q1 (11.44 -1.12) Company warns for Q1 (Mar); sees revenues in the range of $2.2 to $2.7 million versus the current consensus estimate of $4.7 million; expects diluted loss per share in the range of $0.20 to $0.23 versus the current consensus estimate for a net loss of $0.18 per share. 16:40 ET After Hours Movers Prices vs 4 pm ET close -- NOVN +2.60 solidly higher on its announcement of favorable Phase III trial results; DCTM -0.91 selling off on the company's announcement of a convertible offering despite raising revenue guidance; EPNY -0.61 also lower after trimming its Q1 revenue forecast. 16:22 ET SBYN SeeBeyond trims Q1 rev forecast (7.97 +0.32) Co announces that it expects to report Q1 revenue of $42.0-$42.5 mln and pro forma EPS of $0.03, vs consensus of $43.7 mln and $0.03. 16:21 ET Q Qwest Comms conference call tonight (8.00 -0.22) Company will host a conference call on Monday, April 1, 2002 to discuss its annual report on Form 10-K which was filed with the SEC earlier today. The "brief" call will begin at 6:00 p.m. EST. Investors may access a webcast (live and replay) of the call at www.qwest.com/about/investor/meetings